Search

Search Constraints

You searched for: Author/Creator Glund, Stephan

Search Results

1. Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD Study. Issue 3 (September 2021)

2. Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies. (6th April 2017)

3. Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding. Issue 6 (5th February 2019)

4. Pharmacokinetic and pharmacodynamic evaluation of linagliptin in African American patients with type 2 diabetes mellitus. (20th August 2013)

5. Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran. (18th June 2019)

6. Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. Issue 1 (17th November 2017)

7. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. Issue 9994 (15th August 2015)